Blocking GATA6 Alleviates Pyroptosis and Inhibits Abdominal Wall Endometriosis Lesion Growth Through Inactivating the PI3K/AKT Pathway
article
OA: closed
CC0
AI-generated summary
Blocking GATA6 inhibits abdominal wall endometriosis lesion growth and pyroptosis by inactivating the PI3K/AKT pathway.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Endometriosis is a benign gynecological disorder characterized by the abnormal presence of endometrium-like cells, referred to as ectopic tissue, located outside the uterine cavity. Beyond the abnormal proliferation of endometrium-like tissues within and beyond the pelvic cavity, compelling scientific evidence underscores the crucial involvement of the NOD-like receptor NLRP3 inflammasome and pyroptosis in the pathogenesis of EMS. Our investigation has revealed a striking upregulation of the endogenous protein GATA-binding protein 6 (GATA6) in abdominal wall EMS. Notably, the knockdown of GATA6 significantly impaired the viability and migratory potential of primary ectopic endometrial stromal cells (EESCs) while also inhibiting crucial markers of pyroptosis, such as NLRP3, the gasdermin D N-terminal fragment (GSDMD-N), and reactive oxygen species (ROS) levels within these cells. Delving deeper into the underlying mechanisms, we discovered that suppressing GATA6 mitigated the activation of the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT) signaling pathway in EESCs. The administration of 740 Y-P, an agonist of the PI3K/AKT pathway, mitigated the inhibitive actions of GATA6 knockdown on EESCs' growth, migration, and pyroptosis, highlighting the intricate crosstalk between GATA6 and this intricate signaling cascade. In vivo experiments corroborated these findings, demonstrating that reduced GATA6 expression effectively restrained the growth of endometrial lesions and concurrently suppressed pyroptosis, accompanied by a dampening of PI3K/AKT signaling within these lesions. In summary, our study underscores the pivotal role of GATA6 in modulating the growth and pyroptosis of abdominal wall EMS through its regulation of the PI3K/AKT signaling pathway. Silencing GATA6 emerges as a promising approach to alleviate pyroptosis and potentially offers a novel therapeutic angle for managing abdominal wall EMS.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (40)
- A novel mechanism regulating pyroptosis-induced fibrosis in endometriosis via lnc-MALAT1/miR-141-3p/NLRP3 pathway via openalex
- E3 ubiquitin ligase TRIM24 deficiency promotes NLRP3/caspase‐1/IL‐1β‐mediated pyroptosis in endometriosis via openalex
- Endometriosis via openalex
- Endometriosis-Associated Ovarian Carcinomas: How PI3K/AKT/mTOR Pathway Affects Their Pathogenesis via openalex
- Endometriosis: pathogenesis and treatment via openalex
- Eutopic and ectopic stromal cells from patients with endometriosis exhibit differential invasive, adhesive, and proliferative behavior via openalex
- Evaluation of apoptosis and angiogenesis in ectopic and eutopic stromal cells of patients with endometriosis compared to non-endometriotic controls via openalex
- FoxA2 represses ERβ-mediated pyroptosis in endometriosis by transcriptionally inhibiting IGF2BP1 via openalex
- GATA6 expression promoted by an active enhancer may become a molecular marker in endometriosis lesions via openalex
- Genome-Wide DNA Methylation Analysis Predicts an Epigenetic Switch for GATA Factor Expression in Endometriosis via openalex
- Glycyrrhizin inhibits LPS-induced inflammatory mediator production in endometrial epithelial cells via openalex
- Inflammatory Mediators and Pain in Endometriosis: A Systematic Review via openalex
- miR-205-5p inhibits human endometriosis progression by targeting ANGPT2 in endometrial stromal cells via openalex
- New Therapeutics in Endometriosis: A Review of Hormonal, Non-Hormonal, and Non-Coding RNA Treatments via openalex
- Ovarian-like differentiation in eutopic and ectopic endometrioses with aberrant FSH receptor, INSL3 and GATA4/6 expression via openalex
- Pathophysiology, diagnosis, and management of endometriosis via openalex
- Pharmaceuticals targeting signaling pathways of endometriosis as potential new medical treatment: A review via openalex
- PI3K/AKT pathway is altered in the endometriosis patient’s endometrium and presents differences according to severity stage via openalex
- PI3K/AKT signaling pathway associates with pyroptosis and inflammation in patients with endometriosis via openalex
- Regulated Cell Death in Endometriosis via openalex
- The Essential Role of GATA6 in the Activation of Estrogen Synthesis in Endometriosis via openalex
- W4400218478 via openalex
- W2153313709 via openalex
- W2409869285 via openalex
- W2908689100 via openalex
- W2969862138 via openalex
- W3011562658 via openalex
- W3154559539 via openalex
- W3194991018 via openalex
- W4226334054 via openalex
- W4229449688 via openalex
- W4296161377 via openalex
- W4362716113 via openalex
- W4365810915 via openalex
- W4379011898 via openalex
- W4385437710 via openalex
- W4387300213 via openalex
- W4388673126 via openalex
- W4389978444 via openalex
- W1895653898 via openalex
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-06-11T06:17:12.891333+00:00
License: CC0
· commercial use OK